Oncodesign Precision Medicine (XPAR:ALOPM) ROE % Adjusted to Book Value : -17.65% (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Oncodesign Precision Medicine ROE % Adjusted to Book Value?

Oncodesign Precision Medicine's ROE % for the quarter that ended in Dec. 2023 was -143.86%. Oncodesign Precision Medicine's PB Ratio for the quarter that ended in Dec. 2023 was 8.15. Oncodesign Precision Medicine's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was -17.65%.

Oncodesign Precision Medicine ROE % Adjusted to Book Value Historical Data

The historical data trend for Oncodesign Precision Medicine's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oncodesign Precision Medicine ROE % Adjusted to Book Value Chart

Oncodesign Precision Medicine Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

-1.21

-12.83

Oncodesign Precision Medicine Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial			-	40.19	-28.32	-17.65	-

Competitive Comparison of Oncodesign Precision Medicine's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Oncodesign Precision Medicine's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oncodesign Precision Medicine's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oncodesign Precision Medicine's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Oncodesign Precision Medicine's ROE % Adjusted to Book Value falls into.

Save Embed

;

Save Embed

;

Oncodesign Precision Medicine ROE % Adjusted to Book Value Calculation

Oncodesign Precision Medicine's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-104.59%	/	8.15
	=	-12.83%

Oncodesign Precision Medicine's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-143.86%	/	8.15
	=	-17.65%

Oncodesign Precision Medicine ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Oncodesign Precision Medicine's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Oncodesign Precision Medicine Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oncodesign Precision Medicine SA (XPAR:ALOPM) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

ZR8:Germany

Address

18 rue Jean Mazen, Dijon, FRA, 21000

Website

https://www.opm.oncodesign.com

Oncodesign Precision Medicine SA is a biopharmaceutical company specialised in precision medicine. Its mission is to provide patients with effective diagnostic and therapeutic solutions for resistant and metastatic cancers.

Oncodesign Precision Medicine Headlines

No Headlines